Wall Street News Alert: Hot Stock to Watch: Caleco Pharma Corp. -- February 24, 2010
February 24 2010 - 9:38AM
Marketwired
Wall Street News Alert's "stocks to watch" this morning are: Caleco
Pharma Corp. (OTCBB: CAEH), Pfizer Inc. (NYSE: PFE), XenoPort Inc
(NASDAQ: XNPT) and Gilead Sciences, Inc. (NASDAQ: GILD).
Caleco Pharma Corp. (OTCBB: CAEH), a biopharmaceutical and
consumer health products company, issued a press release yesterday
providing insight into the development strategy for its lead,
patent protected product line that targets a segment of the market
that includes millions of people suffering from various liver
maladies, especially the Hepatitis C Virus (HCV).
"Pre-clinical research and an observational study have indicated
that products derived from the company's proprietary "Liver Health"
formulation, exhibit anti-viral activity," said John Boschert,
Caleco's President and CEO. "We will continue pre-clinical work
with these compounds, CPC.12115HP201 and CPC.12115HP202 in 2010
focusing on developing and testing additional derivatives as well
as further compound isolation work on the parent herbal
formulation. With the anti-viral activity profiles having been
demonstrated in two bioassay systems, and considering the observed
clinical effects of the parent herbal formulation, the Corporation
believes continued preclinical development work is warranted.
The company is pursuing a two-tiered strategy to bring the
parent herbal formulation to market while continuing development of
CPC.12115HP201 and CPC.12115HP202. The company is actively engaged
in pre-commercialization projects related to bringing the
proprietary "Liver Health" formulation to worldwide markets as an
oral health supplement following additional clinical trials
expected to start in the first half of 2010. In addition,
derivatives of the parent herbal formulation are being considered
for oral supplement development targeted at immune system
enhancement and as dermatologic products for use in common chronic
dermatologic conditions.
To date, the Company's intellectual property covering the "Liver
Health" formulations is comprised of patent applications in the
United States, Europe and Canada and four European Drug Master File
applications.
Additional information is available on the company's website at:
http://www.calecopharmacorp.com/.
The stock closed yesterday at Twenty cents a share.
For an in-depth profile of Caleco Pharma, visit
http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=CAEH_022310.
To receive FREE Mobile Stock Alerts formatted especially for
your cell phone, text the word "press" in the subject line to
68494.
For more information, please visit www.WallStreetNewsAlert.com
and you can also follow Wall Street News Alerts on Twitter at
http://twitter.com/wsna
Pfizer Inc. (NYSE: PFE) down 1.5% on 47.8 million shares traded.
At Pfizer, we apply science and our global resources to improve
health and well-being at every stage of life.
XenoPort Inc (NASDAQ: XNPT) down 9.8% on 12 million shares
traded. XenoPort, Inc. is a biopharmaceutical company focused on
developing a portfolio of internally discovered product candidates
that utilize the body's natural nutrient transport mechanisms to
improve the therapeutic benefits of existing drugs.
Gilead Sciences, Inc. (NASDAQ: GILD) down 1.1% on 10 million
shares traded. Gilead Sciences is a biopharmaceutical company that
discovers, develops and commercializes innovative therapeutics in
areas of unmet medical need.
Market Commentary: Home prices edged up in December, the seventh
straight monthly gain and another sign the housing market continues
its bumpy recovery.
Let Wall Street News Alert help advertise for your company using
our effective awareness campaigns. If you're Interested in telling
your story, we can help. Contact us at
info@wallstreetnewsalert.com
WSNA's email alert service is free to those investors who sign
up on the WSNA home page. The alert service is designed to notify
investors of often-overlooked stocks. Subscribers are introduced to
Special Situation companies that have the potential of showing
increased activity. The Wall Street News Alert home page has
experienced over 200 million hits. To subscribe to this free
service, visit the Wall Street News Alert home page at
http://www.wallstreetnewsalert.com.
*** It has come to the
attention of Wall Street News Alert (WSNA), that various persons or
companies distribute faxes bearing similar names to Wall Street
News Alert. Wall Street News Alert is not affiliated with faxes
bearing names such as: Wall Street Stock Alert, Wall Street
Investor Alert, Wall Street News Alert or any other fax using
various combinations of the generic words Wall
Street.***
Wall Street News Alert is a division of Wall Street Capital
Funding LLC (WSCF). WSCF also maintains a contractual, working
relationship with Stock Market Alerts LLC and its Wall Street Enews
brand. WSCF is not a registered broker/dealer and may not sell,
offer to sell or offer to buy any security. WSCF profiles are not a
solicitation or recommendation to buy, sell or hold securities. An
offer to buy or sell can be made only with accompanying disclosure
documents from the company offering or selling securities and only
in the states and provinces for which they are approved. The
material in this release is intended to be strictly informational.
The companies that are discussed in this release have not approved
the statements made in this release nor approved the timing of this
release. All statements and expressions are the sole opinion of
WSCF and are subject to change without notice. Information in this
release is derived from a variety of sources including that
company's publicly disseminated information, third parties and WSCF
research. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was
obtained. WSCF disclaims any and all liability as to the
completeness or accuracy of the information contained and any
omissions of material fact in this release. The release may contain
technical inaccuracies or typographical errors. It is strongly
recommended that any purchase or sale decision be discussed with a
financial adviser, or a broker-dealer, or a member of any financial
regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high
degree of risk. WSCF is not liable for any investment decisions by
its readers or subscribers. Investors are cautioned that they may
lose all or a portion of their investment if they make a purchase
in WSCF profiled stocks.
This profile is not without bias, and is a paid release. WSCF
has been compensated for dissemination of company information on
behalf of one or more of the companies mentioned in this release.
For current services performed for Caleco Pharma Corp. (OTCBB:
CAEH), WSCF has been compensated Forty Thousand Dollars, by a third
party who is non-affiliated and may hold a significant position in
the stock. WSCF holds no shares of the stock. WSCF may receive
additional compensation for extension of its services. Any
additional compensation will be disclosed at such time that WSCF is
aware of a client's desire to extend the original services. WSCF
may have received shares of a company profiled in this release
prior to the dissemination of the information in this release. WSCF
may immediately sell some or any shares in a profiled company held
by WSCF and may have previously sold shares in a profiled company
held by WSCF. WSCF's services for a company may cause the company's
stock price to increase, in which event WSCF would make a profit
when it sells its stock in a company. In addition, WSCF's selling
of a company's stock may have a negative effect on the market price
of the stock.
This release contains "forward-looking statements" within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words
such as "may," "future," "plan" or "planned," "will" or "should,"
"expected," "anticipates," "draft," "eventually" or "projected."
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company's annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and WSCF undertakes no
obligation to update such statements.
Contact Wall Street News Alert email: Email Contact URL:
http://www.wallstreetnewsalert.com
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Jul 2023 to Jul 2024